What type of study is this?

This is a Cross-Sectional Study study.

What question did this study set out to answer?

This research evaluates the long-term burden of G6PD deficiency worldwide over three decades.

December 8, 2025BloodOpen Access

Global, regional, and national burden of G6PD deficiency: A three-decade analysis across 204 countries

View Full Paper

Ask AI

Bookmark

This research evaluates the long-term burden of G6PD deficiency worldwide over three decades.
Ecological cross-sectional analysis of Global Burden of Disease data from 1990 to 2021.
Estimates of disability-adjusted life years, years of life lost, and prevalence extracted for 204 countries.
Countries ranked by aggregate burden and selected for longitudinal analysis.
China had the highest G6PD-related DALY burden in 2021 but showed a 12.7% decline since 1990.
India's DALYs increased by 75.4%, and Nigeria's nearly doubled, while Bangladesh and Indonesia saw reductions.
Prevalence of G6PD deficiency rose in all five countries, with China reporting 66.1 million cases, a 64.4% increase.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Ecological analysis reveals rising G6PD prevalence in India and Nigeria, while Bangladesh and Indonesia see reductions, indicating health system needs.

Cite This Study

Daaniya Tariq (2025) studied this question.

synapsesocial.com/papers/693624d74fa91c937236d17c https://doi.org/10.1182/blood-2025-6435

View Full Paper

Ask AI

Bookmark

Implication

Ecological analysis reveals rising G6PD prevalence in India and Nigeria, while Bangladesh and Indonesia see reductions, indicating health system needs.

Global, regional, and national burden of G6PD deficiency: A three-decade analysis across 204 countries

Key Points

Discussion

Implication

Cite This Study

Global, regional, and national burden of G6PD deficiency: A three-decade analysis across 204 countries

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider